Financial

The two companies will integrate LifeScan's OneTouch Verio Flex blood glucose monitoring system with WellDoc's BlueStar diabetes management platform.

The Series E round was co-led by Norwest Venture Partners, the lead investor in three previous rounds, and UPMC, an existing Health Catalyst customer.

Under the deal, UPMC is purchasing stock from existing non-employee medCPU shareholders and expects to hold majority ownership by the end of Q2 2016.

The company's solution is in use by over 500 hospitals and payers to efficiently manage, monitor and engage patient populations of all sizes and risk levels.

The company has just raised less than $1 million from Launchpad Digital Health to expand its staff and scale to more deployments.

Mutual fund giant Fidelity led the round with participation from Google Capital, General Catalyst, Founders Fund, Lakestar, Khosla Ventures and Thrive Capital.

The company will use the funds to make its service available in 46 states within the next year, up from 33 states where it is available today.

The company has developed a mobile app that provides therapy to patients who have traumatic brain injury, stroke, aphasia, and learning disabilities.

The company was founded by Stanford Biodesign 2012 fellow Kate Rosenbluth who won a $10,000 "Boomer" award and $25,000 from a UC Berkeley startup competition.

Launched in 2011, the company has developed a set of APIs that allow healthcare companies to more easily build out apps and services.